Insulin resistance in polycystic ovary syndrome

被引:5
|
作者
Schröder, AK
Tauchert, S
Ortmann, O
Diedrich, K
Weiss, JM
机构
[1] Univ Klinikum Schleswig Hostein, Klin Frauenheilkunde & Geburtshilfe, D-23538 Lubeck, Germany
[2] Univ Klinikum Regensburg, Caritas Krankenhaus St Josef, Klin Frauenheilkunde & Geburtshilfe, Regensburg, Germany
关键词
polycystic ovary syndrome; PCOS; insulin resistance; diabetes mellitus; cardiovascular risk; risks; IMPAIRED GLUCOSE-TOLERANCE; TYPE-2; DIABETES-MELLITUS; GROWTH-FACTOR-I; METFORMIN THERAPY; OBESE WOMEN; CARDIOVASCULAR-DISEASE; RISK-FACTORS; YOUNG-WOMEN; LIFE-STYLE; PREVALENCE;
D O I
10.1007/BF03041041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With a prevalence of 5-10% the polycystic ovary syndrome (PCOS) is a common disorder of premenopausal women. According to prospective studies abnormal glucose tolerance and diabetes mellitus present in about 10.0% and 35.0% of adult women with PCOS, respectively. PCOS patients have a higher prevalence of cardiovascular risk factors such as hypertension and dyslipidaemia. The rate of spontaneous abortions as well as the risk of developing gestational diabetes is increased in PCOS. Therefore, PCOS is not only a reproductive problem, but a complex endocrine disease with important health implications. The role of glucose metabolism in PCOS, the health consequences and possible interventions are reviewed in this article.
引用
收藏
页码:812 / 821
页数:10
相关论文
共 50 条
  • [21] The role of insulin resistance in polycystic ovary syndrome
    Legro, RS
    Dunaif, A
    ENDOCRINOLOGIST, 1996, 6 (04): : 307 - 321
  • [22] Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome
    Hong, So-hyeon
    Sung, Yeon-Ah
    Hong, Young Sun
    Jeong, Kyungah
    Chung, Hyewon
    Lee, Hyejin
    CLINICAL ENDOCRINOLOGY, 2017, 87 (04) : 375 - 380
  • [23] Markers of insulin resistance and metabolic syndrome in polycystic ovary
    Trimeche, S.
    Safer, M. Abid
    Chaieb, M. Chadli
    Ajina, M. Zaouali
    Elghezal, R. Braham
    Beizig, A. Maaroufi
    Ach, K.
    Njah, M. Kacem
    Chaieb, L.
    DIABETES & METABOLISM, 2011, 37 : A70 - A70
  • [24] Current perspectives of insulin resistance and polycystic ovary syndrome
    Pauli, J. M.
    Raja-Khan, N.
    Wu, X.
    Legro, R. S.
    DIABETIC MEDICINE, 2011, 28 (12) : 1445 - 1454
  • [25] Limitations of insulin resistance assessment in polycystic ovary syndrome
    Lewandowski, Krzysztof C.
    Plusajska, Justyna
    Horzelski, Wojciech
    Bieniek, Ewa
    Lewinski, Andrzej
    ENDOCRINE CONNECTIONS, 2018, 7 (03): : 403 - 412
  • [26] Polycystic Ovary Syndrome, Insulin Resistance, and Cardiovascular Disease
    Dubey, Pallavi
    Reddy, Sireesha
    Sharma, Kunal
    Johnson, Sarah
    Hardy, Ghislain
    Dwivedi, Alok Kumar
    CURRENT CARDIOLOGY REPORTS, 2024, 26 (06) : 483 - 495
  • [27] EVIDENCE FOR INSULIN RESISTANCE IN POLYCYSTIC OVARY SYNDROME (PCO)
    LOBO, RA
    SHOUPE, D
    CLINICAL RESEARCH, 1983, 31 (01): : A57 - A57
  • [28] New markers of insulin resistance in polycystic ovary syndrome
    K. Polak
    A. Czyzyk
    T. Simoncini
    B. Meczekalski
    Journal of Endocrinological Investigation, 2017, 40 : 1 - 8
  • [29] Prediction models for insulin resistance in the polycystic ovary syndrome
    Gennarelli, G
    Holte, J
    Berglund, L
    Berne, C
    Massobrio, M
    Lithell, H
    HUMAN REPRODUCTION, 2000, 15 (10) : 2098 - 2102
  • [30] Molecular mechanisms of insulin resistance in polycystic ovary syndrome
    Diamanti-Kandarakis, Evanthia
    Papavassiliou, Athanasios G.
    TRENDS IN MOLECULAR MEDICINE, 2006, 12 (07) : 324 - 332